Seroprevalence of human enterovirus 71 and coxsackievirus A16 in Guangdong, China, in pre- and post-2010 HFMD epidemic period

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Li, Wei ^a   Yi, Lina ^a   Su, Juan ^a   Lu, Jing ^a   Ke, Changwen ^a   Zeng, Hanri ^a   Guan, Dawei ^a   Ma, Cong ^a   Zhang, Wanly ^a   Xiao, Hong ^a   Li, Hui ^a   Lin, Jinyan ^a   Zhang, Yonghui ^a  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

AGE; ANTIBODY TITER; ARTICLE; CHILD; CHINA; CONTROLLED STUDY; COXSACKIE VIRUS A; COXSACKIE VIRUS A16; COXSACKIE VIRUS INFECTION; CROSS-SECTIONAL STUDY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; EPIDEMIC; FEMALE; HAND FOOT AND MOUTH DISEASE; HUMAN; IMMUNITY; INFECTION SENSITIVITY; MALE; SEROPREVALENCE; VIRUS NEUTRALIZATION;

ADULT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHINA; DISEASE OUTBREAKS; ENTEROVIRUS A, HUMAN; FEMALE; HAND, FOOT AND MOUTH DISEASE; HUMANS; INFANT; MALE; SEROEPIDEMIOLOGIC STUDIES;

EID: 84891899622     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080515     Document Type: Article

References (37)

1. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, et al. (2010) Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 10: 778-790.
2. Yi L, Lu J, Kung HF, He ML (2011) The virology and developments toward control of human enterovirus 71. Crit Rev Microbiol 37: 313-327.
3. McMinn PC (2002) An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 26: 91-107.
4. Denizot M, Neal JW, Gasque P (2012) Encephalitis due to emerging viruses: CNS innate immunity and potential therapeutic targets. J Infect 65: 1-16.
5. Koroleva GA, Lukashev AN, Khudiakova LV, Mustafina AN, Lashkevich VA (2011) [Encephalomyelitis caused by enterovirus type 71 in children]. Vopr Virusol 55: 4-10.
6. Wu Y, Yeo A, Phoon MC, Tan EL, Poh CL, et al. (2010) The largest outbreak of hand; foot and mouth disease in Singapore in 2008: the role of enterovirus 71 and coxsackievirus A strains. Int J Infect Dis 14: e1076-1081.
7. Zou XN, Zhang XZ, Wang B, Qiu YT (2012) Etiologic and epidemiologic analysis of hand, foot, and mouth disease in Guangzhou city: a review of 4,753 cases. Braz J Infect Dis 16: 457-465.
8. Weng KF, Chen LL, Huang PN, Shih SR (2010) Neural pathogenesis of enterovirus 71 infection. Microbes Infect 12: 505-510.
9. McMinn PC (2012) Recent advances in the molecular epidemiology and control of human enterovirus 71 infection. Curr Opin Virol 2: 199-205.
10. Meng FY, Li JX, Li XL, Chu K, Zhang YT, et al. (2012) Tolerability and immunogenicity of an inactivated enterovirus 71 vaccine in Chinese healthy adults and children: an open label, phase 1 clinical trial. Hum Vaccin Immunother 8: 668-674.
11. Li YP, Liang ZL, Xia JL, Wu JY, Wang L, et al. (2013) Immunogenicity, Safety, and Immune persistence of A Novel Inactivated Human Enterovirus 71 (EV71) Vaccine: A Phase II, Randomized, Double-Blind, Placebo-Controlled trial. J Infect Dis.
12. Liang ZL, Mao QY, Wang YP, Zhu FC, Li JX, et al. (2013) Progress on the research and development of inactivated EV71 whole-virus vaccines. Hum Vaccin Immunother 9.
13. Zhu FC, Meng FY, Li JX, Li XL, Mao QY, et al. (2013) Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 381: 2024-2032.
14. Lee MS, Chiang PS, Luo ST, Huang ML, Liou GY, et al. (2012) Incidence rates of enterovirus 71 infections in young children during a nationwide epidemic in Taiwan, 2008-09. PLoS Negl Trop Dis 6: e1476.
15. Guan D, van der Sanden S, Zeng H, Li W, Zheng H, et al. (2012) Population dynamics and genetic diversity of C4 strains of human enterovirus 71 in Mainland China, 1998-2010. PLoS One 7: e44386.
16. Tan X, Huang X, Zhu S, Chen H, Yu Q, et al. (2011) The persistent circulation of enterovirus 71 in People's Republic of China: causing emerging nationwide epidemics since 2008. PLoS One 6: e25662.
17. Fan X, Jiang J, Liu Y, Huang X, Wang P, et al. (2012) Detection of human enterovirus 71 and Coxsackievirus A16 in an outbreak of hand, foot, and mouth disease in Henan Province, China in 2009. Virus Genes.
18. Yan XF, Gao S, Xia JF, Ye R, Yu H, et al. (2011) Epidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with coxsackievirus A16. Scand J Infect Dis 44: 297-305.
19. Zeng M, El Khatib NF, Tu S, Ren P, Xu S, et al. (2012) Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai. J Clin Virol 53: 285-289.
20. Deng T, Huang Y, Yu S, Gu J, Huang C, et al. (2013) Spatial-temporal clusters and risk factors of hand, foot, and mouth disease at the district level in Guangdong Province, China. PLoS One 8: e56943.
21. Sun LM, Zheng HY, Zheng HZ, Guo X, He JF, et al. (2011) An enterovirus 71 epidemic in Guangdong Province of China, 2008: epidemiological, clinical, and virogenic manifestations. Jpn J Infect Dis 64: 13-18.
22. Dudareva S, Schweiger B, Thamm M, Hohle M, Stark K, et al. (2011) Prevalence of antibodies to 2009 pandemic influenza A (H1N1) virus in German adult population in pre- and post-pandemic period. PLoS One 6: e21340.
23. Tarr AW, Urbanowicz RA, Ball JK (2012) The role of humoral innate immunity in hepatitis C virus infection. Viruses 4: 1-27.
24. Yu H, Wang M, Chang H, Lu J, Lu B, et al. (2011) Prevalence of antibodies against enterovirus 71 in children from Lu'an City in Central China. Jpn J Infect Dis 64: 528-532.
25. Ji H, Li L, Liu Y, Ge H, Wang X, et al. (2012) Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province, China. Virol J 9: 248.
26. Yang F, He J, Zhong H, Ke C, Zhang X, et al. (2012) Temporal trends of influenza A (H1N1) virus seroprevalence following 2009 pandemic wave in Guangdong, China: three cross-sectional serology surveys. PLoS One 7: e38768.
27. Huang WC, Huang LM, Kao CL, Lu CY, Shao PL, et al. (2011) Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city. J Microbiol Immunol Infect 45: 96-101.
28. Ang LW, Phoon MC, Wu Y, Cutter J, James L, et al. (2011) The changing seroepidemiology of enterovirus 71 infection among children and adolescents in Singapore. BMC Infect Dis 11: 270.
29. Bland JM, Altman DG (1996) The use of transformation when comparing two means. BMJ 312: 1153.
30. Zhu FC, Liang ZL, Meng FY, Zeng Y, Mao QY, et al. (2012) Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants. PLoS One 7: e37206.
31. Mao Q, Dong C, Li X, Gao Q, Guo Z, et al. (2012) Comparative analysis of the immunogenicity and protective effects of inactivated EV71 vaccines in mice. PLoS One 7: e46043.
32. Zhu Z, Zhu S, Guo X, Wang J, Wang D, et al. (2010) Retrospective seroepidemiology indicated that human enterovirus 71 and coxsackievirus A16 circulated wildly in central and southern China before large-scale outbreaks from 2008. Virol J 7: 300.
33. Lee MS, Lin TY, Chiang PS, Li WC, Luo ST, et al. (2010) An investigation of epidemic enterovirus 71 infection in Taiwan, 2008: clinical, virologic, and serologic features. Pediatr Infect Dis J 29: 1030-1034.
34. Diedrich S, Weinbrecht A, Schreier E (2009) Seroprevalence and molecular epidemiology of enterovirus 71 in Germany. Arch Virol 154: 1139-1142.
35. Ooi EE, Phoon MC, Ishak B, Chan SH (2002) Seroepidemiology of human enterovirus 71, Singapore. Emerg Infect Dis 8: 995-997.
36. Mao Q, Li N, Yu X, Yao X, Li F, et al. (2011) Antigenicity, animal protective effect and genetic characteristics of candidate vaccine strains of enterovirus 71. Arch Virol 157: 37-41.
37. Rabenau HF, Richter M, Doerr HW (2009) Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany. Med Microbiol Immunol 199: 45-51.